Mesa Laboratories (MLAB)
(Delayed Data from NSDQ)
$126.18 USD
+3.70 (3.02%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $125.71 -0.47 (-0.37%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$126.18 USD
+3.70 (3.02%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $125.71 -0.47 (-0.37%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Zacks News
Mesa Laboratories and Disney have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Mesa Laboratories and Disney have been highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Mesa Laboratories (MLAB)
by Kevin Cook
Another solid quarter and growth ahead in genetic diagnostic services makes this small cap a buy
Mesa Labs (MLAB) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Mesa Labs (MLAB) delivered earnings and revenue surprises of 44.96% and 2.55%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Mesa Labs (MLAB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Labs, Equinox Gold, General Motors, Tesla and Ford Motor highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Mesa Labs, Equinox Gold, General Motors, Tesla and Ford Motor highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Mesa Laboratories (MLAB)
by Kevin Cook
Key M&A boosts sales & EPS, opens path to new business with Clinical Genomics Division
Mesa Labs (MLAB) Moves 4.5% Higher: Will This Strength Last?
by Zacks Equity Research
Mesa Labs (MLAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Mesa Labs (MLAB) Lags Q1 Earnings Estimates
by Zacks Equity Research
Mesa Labs (MLAB) delivered earnings and revenue surprises of -5.88% and 2.41%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Mesa Labs (MLAB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for June 14th
by Zacks Equity Research
CPB, MLAB, TMQ, CGAU, and BHVN have been added to the Zacks Rank #5 (Strong Sell) List on June 14, 2021
Mesa Labs (MLAB) to Report Q4 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Labs (MLAB) Lags Q3 Earnings Estimates
by Zacks Equity Research
Mesa Labs (MLAB) delivered earnings and revenue surprises of -0.68% and 5.79%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs (MLAB) Earnings Expected to Grow: What to Know Ahead of Q3 Release
by Zacks Equity Research
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PerkinElmer (PKI) to Buy Oxford Immunotec for $591 million
by Zacks Equity Research
PerkinElmer's (PKI) acquisition of Oxford Immunotec will expand its portfolio of advanced infectious disease testing solutions.
Mesa Labs (MLAB) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Mesa Labs (MLAB) delivered earnings and revenue surprises of 78.50% and 5.25%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Mesa Labs (MLAB) Q2 Earnings Expected to Decline
by Zacks Equity Research
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bloomin' Brands, Mesa Laboratories, Intuit, Target and Microsoft highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Bloomin' Brands, Mesa Laboratories, Intuit, Target and Microsoft highlighted as Zacks Bull and Bear of the Day
Keysight, Mesa, Costco and Novavax as Zacks Bull and Bear of the Day
by Zacks Equity Research
Keysight, Mesa, Costco and Novavax as Zacks Bull and Bear of the Day
Bear of the Day: Mesa Labs (MLAB)
by Kevin Cook
Growth rates have stalled for this small-cap provider of quality control instruments for the medical sector
New Strong Sell Stocks for September 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Mesa Labs (MLAB) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Mesa Labs (MLAB) delivered earnings and revenue surprises of -6.18% and -5.55%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Mesa Labs (MLAB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Labs (MLAB) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Mesa Labs (MLAB) delivered earnings and revenue surprises of -36.45% and -0.85%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.